ASND
Ascendis Pharma A/S
NASDAQ · Healthcare · Biotechnology · DK
$236.72
−0.97%Forward multiples
Based on analyst estimates
- P/E forward
- 33.33x
- P/E 2026E
- 14.61x
- P/E 2027E
- 23.00x
- P/E 2028E
- 14.41x
- P/S forward
- 7.94x
Trailing multiples
Trailing twelve months
- P/E TTM
- 17.04x
- PEG TTM
- —
- Price / book
- 9.45x
- Price / sales
- 12.87x
- Price / cash flow
- 38.62x
Enterprise value
- Enterprise value
- $15.2B
- EV / sales
- 12.52x
- EV / EBITDA
- 169.01x
- EV / EBIT
- 120.64x
- Market cap
- $15.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026